Abstract Epigenetic modification may play an important role in pathophysiology of ischemic stroke (IS) risk. MicroRNAs (miRNAs), which constitute one of the modes of epigenetic regulation, have been shown to be associated with a number of clinical disorders including IS. The purpose of this study was to investigate the miRNA profile in the peripheral blood mononuclear cells (PBMCs) of IS patients and compare it with stroke-free controls. Blood samples were obtained from 19 healthy age-gender-race matched individuals who served as controls to 20 IS patients. miRNA microarray analysis with RNA from PBMCs was performed and significantly dysregulated miRNAs common among IS patients were identified. We identified 117 miRNAs with linear fold values of at least ±1.5, of which, 29 were significantly altered (p value <0.05). Ingenuity Pathway Analysis (IPA) indicated a role for the dysregulated miRNAs in conditions relevant to IS (e.g., organismal injury and abnormalities, hematological disease and immunological disease). Pro-inflammatory genes like STAT3, interleukin (IL) 12A, and IL12B were some of the highly predicted targets for the dysregulated miRNAs. Notably, we further identified three common and significantly upregulated miRNAs (hsa-miR-4656, -432, -503) and one downregulated miRNA (hsa-miR-874) among all IS patients. Molecular interactive network analysis revealed that the commonly dysregulated miRNAs share several targets with roles relevant to IS. Altogether, we report dysregulation of miRNAs in IS PBMCs and provide evidence for their involvement in the immune system alteration during IS pathophysiology.
Introduction
South Carolina, described as Bthe buckle of the Stroke Belt^, has one of the highest age-adjusted stroke mortalities in the USA [1, 2] . The REasons for Geographic And Racial Differences in Stroke (REGARDS) study reported an association between inflammatory markers and stroke among those residing in the Stroke Belt states [1, 3] . Inflammation plays an important role in atherosclerosis, a common mechanism that leads to IS and heart attacks [1, 4] . Recently, data from The Health and Retirement Study (HRS) and REGARDS study demonstrated that exposure to environmental conditions in the Stroke Belt contribute to an increased IS risk [4] . Environmental conditions and physiological stress can alter epigenetic marks resulting in changes in gene expression and translation without altering the DNA sequence [5] . This phenomenon may explain the mechanism by which exposure to environmental conditions in the Stroke Belt could contribute to an increased stroke risk later in life [4] .
Well-recognized epigenetic mechanisms involve the pathways regulating the synthesis and action of miRNA. These miRNAs are small,~22 nucleotide, non-coding RNA [6, 7] Electronic supplementary material The online version of this article (doi:10.1007/s12035-016-0347-8) contains supplementary material, which is available to authorized users. and, they play a key role in gene regulation at different stages of cellular differentiation and development [8, 9] . Moreover, many types of cancers and other human diseases have been associated with the dysregulation of miRNA expression [10] [11] [12] [13] . Because of their master role in gene control, and ease of isolation, miRNAs are emerging as new biomarkers of human disease [14] [15] [16] [17] [18] [19] . Interestingly, there are approximately a dozen miRNAs isolated either from serum, cerebrospinal fluid (CSF), or whole blood from IS patients that are potential biomarker candidates [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . However, to our knowledge, there are no reports on dysregulated miRNAs from the peripheral blood mononuclear cells (PBMCs) of stroke patients.
Peripheral blood mononuclear cells constitute a critical component of the immune system, and previous research has shown that these cells display significant alterations in cytokine production and undergo apoptosis after IS [36] . Ischemic stroke is known to trigger a systemic inflammatory response [37] . Whether such changes are associated with altered miRNA expression in PBMCs has not been previously investigated. Consequently, we profiled miRNAs from acute IS PBMCs by microarray. We observed 117 dysregulated miRNAs and investigated their biological targets and processes using Ingenuity Pathway Analysis (IPA), (QIAGEN, Redwood City, CA, http://www.ingenuity.com/), Panther Pathways [38] , and Cytoscape [39] . We observed that many of the target genes have roles in immune system functioning and biological processes and pathways relevant to stroke. For example, IL12A and IL12B are predicted targets of hsa-miRs-874-3p and -3064-5p, respectively. As another example, STAT3 is targeted by six downregulated miRNAs from our dataset. Furthermore, we found four miRNAs (hsa-miRs-4656, -432, -503 and -874-3p) which are commonly dysregulated in all IS patients analyzed as compared to heathy controls. Therefore, we suggest that these four miRNAs are promising candidates for further study as biomarkers for IS.
Materials and Methods

Patients and Cell Preparation
Ischemic stroke patients admitted to the stroke center at the University of South Carolina Palmetto Health Richland Hospital, Columbia, South Carolina, were recruited for this study after proper consent was obtained. Confirmation of the stroke subtype was done by a vascular neurologist. All blood samples were collected within 48 h of stroke symptom onset. Controls consisted of age, gender, and race matched healthy volunteers without any history of stroke in the individuals or in their family. Twenty mL of peripheral blood was collected in EDTA containing vials (Vacutainer, BD) and processed using Ficoll-Paque (GE Healthcare, Uppsala, Sweden) density centrifugation to isolate PBMCs. Trypan-blue exclusion staining was used to determine the viability of PBMCs. We included 19 controls and 20 IS patients for the present study.
RNA Isolation and miRNA Microarray
Total RNA, including miRNA and other small RNA molecules, was isolated using AllPrep DNA/RNA/miRNA Universal Kit (Qiagen, Valencia, CA) from fresh PBMCs from both control and IS patients. Next, total RNA samples (five each control and IS patient) were used for miRNA array hybridization assay employing GeneChip array (miRNA-3_0). Linear fold-change in miRNA was then calculated to compare the differences in expression of 1009 miRNAs between controls and IS patients.
Data Analysis, Selection of Candidate miRNAs, and Functional Enrichment
First, two-tailed Student's t tests on the expression values of all miRNAs in all the individuals of the control and IS groups were performed. Then, the volcano plot, measuring statistical significance and magnitude of fold-change, was generated based on the log2 fold-change (X-axis) and −log10 p value from Student's t tests (Y-axis). All the dysregulated miRNAs were selected on the basis of linear fold-change cut off of at least ±1.5 in IS compared to controls (a log2 fold-change of 0.6 is~1.5 linear fold-change), and a p value <0.05 was considered significant. Only the miRNAs meeting the above two criteria, highlighted by colored dots in the volcano plot (orange and light blue for greater than ±1.5 and less than ±2; red and dark blue for beyond ±2), were then used to create a Venn diagram with multiple patients (n = 5) to identify the miRNA that are commonly dysregulated in all IS patients. Next, a miRNA-gene interaction network of the dysregulated miRNAs was obtained by employing the IPA tool. IPA is a widely used bioinformatics tool to analyze biological molecule interactions, including miRNA, mRNA, and proteins. IPA was performed with only the miRNA that met the above selection criteria. Further down, the target genes of the dysregulated miRNAwere extracted from IPA for functional analysis using Panther Pathways. Panther is a database maintained by the University of California, Santa Cruz, that is used for functional enrichment of gene products. Finally, the commonly dysregulated miRNAs were selected for further analysis, as they were the most promising based on our set criteria for selection. The targets of these commonly dysregulated miRNAs were extracted from the following databases: www.mirwalk.org, www.mirdb.org and www.microrna.org. The genes that were known or predicted to be targeted by two or more miRNAs from the selected miRNAs (commonly dysregulated miRNAs) were then analyzed by Cytoscape to find their interactions and gene ontology.
Data Validation by qRT-PCR Analysis
Complementary DNA was prepared using the miScript II RT kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Real-time PCR was performed with 3 ng cDNA, for validating the miRNA expression, using miScript Primer Assays and miScript SYBR Green PCR Kit (Qiagen, Valencia, CA) following manufacturer's instructions. We included seven miRNAs (hsa-miRs-503, -376c, -487b, -130a-3p, -432, -4656 and -874-3p) for validation.
Of the numerous target genes revealed based on the miRNA-gene interaction analysis, we selected eight genes (SMAD3, TGFB2, TGFB3, TGFBR1, MKL2, ETS1, IL12A, and IL12B) for expression analysis in PBMCs by qRT-PCR evaluation of their transcripts. Real-time PCR was performed using iQ™ Universal SYBR® Green Supermix (Bio-Rad, USA) by using 25 ng of the cDNA as template. All the qRT-PCR was run in a ViiA7 Real-Time PCR System from Applied Biosystems. SNORD96A and 18S rRNA was used as internal controls for the miRNA and target genes, respectively. Expression level was presented after calculating the fold-change (ΔΔC T ). MicroRNA and the target gene transcript levels were measured in PBMCs from each of the 19 controls and 20 IS patients.
Dual-Luciferase Reporter Assay
We obtained the sequence of only the hsa-miR-432-5p binding sites on the 3′ UTRs of human Tgfb3, Celsr2, and Itm2C (as shown in Fig. 5a ) as per information provided on www. microrna.org. After adding appropriate restriction sites, we procured the oligos from Integrated DNA Technology (IDT, Iowa). The double-stranded oligos were cloned in pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega, cat# E1330). Since the seed sequence of hsa-miR-432-5p was common for all the three genes, we used only one mutant UTR with completely different nucleotides in the seed sequence region. Overnight cultured THP1 cells were transfected simultaneously with the recombinant vectors and the miRNA mimic for hsa-miR-432-5p using lipofectamine 3000 from Invitrogen in separate experiments. After 48 h, luciferase activity was detected using the Dual-Glo® Luciferase Assay System kit from Promega (cat# E2920) following the instructions by the provider.
Statistics
A two-tailed Student's t test was used to calculate p values for miRNA expression level and qRT-PCR data. A p value <0.05 was considered significant. The p values indicated in the pathway and gene ontology analyses were obtained from the respective tools without any changes. To test the reliability of our t test used to identify significantly dysregulated miRNAs, we used power test to calculate the power of our tests (Supplemental Fig. III ).
Results miRNA Expression in PBMCs from IS Patients
A total of 39 participants were included in the analysis (20 IS patients and 19 healthy controls). The mean age for IS patients and controls was 61 and 50 years, respectively. The median NIHSS for the IS group was four with a range of 0-23. By TOAST classification of subtypes of ischemic stroke, the most recurrent source of IS for the case group was cardioembolic (45%). Baseline characteristics for both groups can be found in Table 1 [40] .
We performed miRNA microarray on total RNA from PBMCs from the control and IS patients, on five subjects per group. A total of 1009 miRNA (Fig. 1a, b) were analyzed by microarray. The microarray data was used to identify differentially expressed miRNA after obtaining the linear fold-change of individual miRNA. Based on a ± 1.5 linear fold-change threshold, we observed 117 miRNAs that were either upregulated (n = 76) or Table I ). The linear fold-change value for the most upregulated miRNA (hsa-miR-409-3p) was 4.14 and for the most downregulated miRNA (hsa-miR-3188) was −2.40, in IS when compared to controls. This analysis showed only 29 miRNAs (Fig. 1c ) that were at least ±1.5 fold up-or downregulated in IS patient PBMCs with a p value <0.05 (referred to as Bsignificantly dysregulated miRNAs^). Of the 29 significantly dysregulated miRNAs, eight miRNAs (hsa-miRs-31, -342-5p, -3619,-5p, -4281, -4687-3p, 4739, -874-3p, -877) were significantly downregulated and hsa-miRs-181a*, -199a-3p, -199-b-3p, -223*, -29c, -30b*, -30e*, -424*, -4656, -4667-5p, -625, -628-5p, -629*, -671-3p, -301a, -376c, -409-5p, -432, -454, -503, -550a* were significantly upregulated in the IS patients when compared to healthy controls.
Functional Enrichment and Biological Pathway Analysis
To identify the target genes of the dysregulated miRNAs, we employed IPA to analyze the following: (1) all the 117 dysregulated miRNAs (Supplemental Table I ) and (2) only the 29 significantly dysregulated miRNAs shown in Fig. 1c . The top two networks obtained after IPA analysis with the first group of miRNAs were categorized under the following: (a) organismal injuries and abnormalities, reproductive system disease, and cancer ( Fig. 2a) and (b) cancer, hematological disease, and immunological disease (Supplemental Fig. I ). Under category (a), 112 miRNAs and in category (b), 71 miRNAs were recorded. However, using IPA to investigate only the 29 significantly dysregulated miRNAs (Fig. 2b) , the top network identified was categorized under the following: cancer, organismal injury and abnormalities, reproductive system diseases, with 24 of 29 miRNAs included in the network (Fig. 2c) .
To identify the gene ontologies (GO) for the target genes of the dysregulated miRNAs, all target molecules were extracted from IPA and used for GO analysis using Panther Pathways. Panther analysis provided 12 biological processes and 14 pathways in which the genes were involved (Supplemental Fig. IIA and IIB) . Within the biological process, the majority of the genes were included under Bcellular, metabolic and developmental processes.Â mong the various pathways, majority of the genes were involved in the Wnt signaling and P53 pathways. Protein class and molecular function classification of the genes indicated that many of them are receptors and transporters (Supplemental Fig. IIC and IID) . Many of the receptors are members of the GPCR (G-protein coupled receptors) 
Identification of commonly dysregulated miRNAs in IS patients and functional enrichment of targets
Next, we identified miRNA that are commonly dysregulated in all five IS patient samples when compared to controls, assayed by the microarray. Consequently, we found only six dysregulated miRNAs (hsa-miRs-4656, -432, -487b, -503, -409-3p, and -874-3p) (Fig. 3a, b , Table 2 ) that were found in all IS patient PBMCs. Of the six commonly dysregulated miRNAs, only hsa-miR-874-3p was downregulated and the rest were upregulated in all five IS patients compared to controls (Table 2) . Only the hsa-miRs-432-5p, -503, -4656, and -874-3p had significant p value (<0.05). Thus, these four miRNAs were used for further analysis. The targets of the select miRNAs were obtained from three databases (www. mirwalk.org, www.mirdb.org, and www.microrna.org) and analyzed in Cytoscape to generate the miRNA-gene interaction network. We found that many of the target genes were strongly predicted to be common targets of two or more of the select miRNAs (Fig. 3c) . Functional enrichment of the common targets of the dysregulated miRNAs indicated that the top gene ontology is the following: cellular differentiation and developmental process (Supplemental Table II) .
qRT-PCR Validation of Select miRNAs and Target Genes
To validate our miRNA microarray data, we performed qRT-PCR analysis for seven miRNAs (Fig. 4a, b) using cDNA samples prepared from total RNA of PBMCs from 19 healthy C control, S ischemic stroke, LFC linear fold-change, m male, f female controls and 20 IS patients. The hsa-miRs-4656, -432, -503, -376c, -130a-3p, and -487b were upregulated and hsa-miR-874-3p was downregulated as per our microarray analysis and similar results were observed after qRT-PCR. The hsamiRs-4656, -432, -503, and -487b were among the commonly upregulated in all IS patients included in the microarray relative to controls and in more than 90% when validated by qRT-PCR. To confirm that our microarray data was reliable, we included hsa-miR-320a for the qRT-PCR validation. This miRNA was shown by microarray to have similar expression levels in the controls and IS patients (1.01 linear fold-changes). Our qRT-PCR analysis also showed similar expression level for the miRNA in both controls and patients (Fig. 4b) . Next, we selected eight genes (SMAD3, TGFB2, TGFB3, TGFBR1, MKL2, ETS1, IL12A, and IL12B) that were predicted to be targets of dysregulated miRNAs from our dataset and performed qRT-PCR to quantify their transcript level in the PBMCs. Our qRT-PCR analysis showed that SMAD3, TGFB2, TGFB3, TGFBR1, MKL2, and ETS1 were downregulated, and IL12A and IL12B were upregulated in the PBMCs of IS patients (Fig. 4c) . As expected, expression of the target genes inversely correlated with the expression of the miRNAs predicted to target them.
Validation of miRNA and Target Gene UTR Interaction
We selected three genes (human TGFB3, CELSR2, and ITM2C) for the study of the miRNA and target gene interaction. These genes were selected as they were predicted to be targets (Fig. 5a ) of the dysregulated miRNA, hsa-miR432-5p, as per analysis presented in Fig. 2c and also targeted by more than one dysregulated miRNAs (hsa-miR-432-5p, and miR4656a), as per evidence provided in Fig. 4c . The hsa-miR-432-5p was selected to study further as it was one of the significantly dysregulated miRNAs present in all the IS patients (commonly dysregulated) included for the study. Dual luciferase reporter assay performed after 48 h of transfection with the miRNA mimic along with the cloned UTR showed almost 50% significant reduction in the luciferase activity compared to the mutant sequence of UTRs (Fig. 5b) and control.
Discussion
The current study was initiated to identify dysregulated miRNAs in the PBMCs that could be used as epigenetic markers of ischemic stroke risk. Consequently, we first noted dysregulated miRNA based only on the level of their expression by setting a threshold of ±1.5 linear fold-change and p < 0.05. Based on this, we found 117 miRNAs that were dysregulated in the PBMCs of IS. As expected, approximately a dozen of the miRNAs from our dataset were reported in studies of miRNAs isolated either from experimental mouse models of IS, human serum samples, CSF, or whole blood cells from IS patients [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . This observation indicated that irrespective of the cells or clinical material used for the analysis, these miRNAs are dysregulated in IS thereby, further suggesting that the changes in microRNA seen in IS may be systemic and that PBMCs may represent a convenient target to study microRNA changes.
One of the main observations from our miRNA-gene interaction analyses is that various genes involved in the immune system pathways are targets of many of the dysregulated miRNAs. For example, STAT3 is targeted by six downregulated miRNAs (hsa-miRs-3064-5p, -4651, -3935, -1207-5p, -4434, and -874-3p) from our dataset, implying that STAT3 could be upregulated during IS. STAT3 is expressed in a diverse array of tissues and cells compared to other members of the STAT family. Depending on the type of signaling cytokine, activation of STAT3 is shown to have a pleiotropic effect [41] . For example, in the presence of IL-6, pro-inflammatory activity of STAT3 is rapidly induced in dendritic cells [42] . Systemic induction of pro-inflammatory cytokines within 24 h of stroke incidence has been reported [37] . Thus, our data imply that pro-inflammatory cytokine induction can occur after IS through involvement of the STAT3 signaling pathway. As another example, we observed that miRNAs targeting IL12A and IL12B (hsa-miR-874-3p and hsa-miR-3064-5p, respectively) are downregulated in the PBMCs of IS patients. We confirmed higher transcript levels for both the genes in the IS PBMCs. IL12A and IL12B are monomers of the functionally active IL12 p40, which acts as a pro-inflammatory cytokine involved in the JAK/STAT signaling pathway to induce interferon (IFN). Serum IL12 is elevated after IS incidence [43] but, there is no report correlating its elevated expression with dysregulated miRNAs in IS. Together, these observations imply a role for dysregulated miRNAs in the control of the expression of pro-inflammatory cytokines during IS.
Hematological and immunological disease was one of the top networks that we identified in IS using IPA. Correlating with this, increased neutrophil count in IS may contribute to pathogenesis [44, 45] . We have also recorded a higher neutrophil count in IS patients (unpublished data). Analysis for GO and biological processes of the dysregulated miRNA targets revealed Bimmune system process^(GO:0002376) as one of the top biological processes. An altered immune response during acute IS onset has been reported previously [36, 37, 46, 47] . GO analysis indicated BToll receptor signaling pathway( P00054) as one of the top ontologies. Toll-like receptors (TLRs) influence the body's response to numerous forms of , and ITM2C. a Nucleotide sequence of hsa-miR-432-5p and the UTR of the genes predicted to interact with miR-432-5p. The sequence details, miRSVR and PhastCons scores were obtained from www. microrna.org. b The UTRs were cloned into pmiRGLO vector and cotransfected with the hsa-miR-432-5p mimics into THP1 cells for luciferase activity measurement. The bar graph shows the relative luciferase activity 48 h after transfection with the different recombinant vectors compared to control and mutant. Because the seed sequence complementary bases were the same for all the three UTRs, we used only one mutant which had all seven nucleotides of the seed sequence changed injury. Furthermore, the TLR signaling pathway has been associated with IS as neuroprotective if stimulation of this pathway is achieved before ischemia [48] .
Ischemic stroke involves injury and damage to brain cells and tissues. Functional enrichment by IPA of the dysregulated miRNAs revealed Borganismal injury and abnormality^as the top network. Inhibition of miR-329, miR-487b, miR-494, and miR-495 improves neovascularization after ischemia in animal studies [49] . These miRNAs were upregulated in IS patients in our study. Interestingly, hsa-miR-376c is in the same genomic cluster as hsa-miR-487b (www.mirbase.org). Our microarray and qRT-PCR analysis both showed upregulation of this miRNA in IS patients. Altogether, these observations suggest that the expression of miRNA which are negatively involved in the vascularization process are upregulated in IS and may exacerbate the disease outcome.
Studies have reported dysregulated miRNAs in the serum, whole blood cells, or cerebrospinal fluids during IS [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . Therefore, we were interested in finding novel miRNAs in the IS PBMCs that could serve as biomarkers for IS. Consequently, for the first time, we identified four differentially expressed miRNAs (hsa-miRs-4656, -432 -503, and hsa-miR-874-3p, referred as select miRNAs) in the PBMCs from IS patients. Even after employing specific selection criteria (at least ±1.5 linear fold-change, p value ≤0.05 and commonly dysregulated in all IS patients tested), these miRNAs were found to be significantly dysregulated in all IS patient samples analyzed by microarray and in >90% of the samples (n = 19) after qRT-PCR validation, indicating that these miRNAs could serve as reliable epigenetic markers. Molecular interactive network analysis of the select miRNAs showed that more than one miRNA targets the same gene(s) (Fig. 3c) . The major biological processes included cellular development, nervous system development, generation of neurons, etc., which are relevant to the pathophysiology of IS. This information clearly indicates roles for the select miRNAs in IS and thus further studies are warranted. Furthermore, South Carolina is one of the several states considered as having a particularly high rate of stroke nationally by US Center for Disease Control and Prevention (CDC) [50] . Our study samples were all collected from South Carolina and there is no previous report on miRNA expression profiles in PBMCs from the Stroke Belt region. A deeper study of the miRNAs in this report may enable identification of markers unique to those at risk for stroke.
To prove that the miRNAs commonly dysregulated in all the IS patients indeed interact with the predicted genes as per our analysis, we chose to study the interaction of hsa-miR-432-5p with the UTRs of human TGFB3, CELSR2 and ITM2C. We found that luciferase activity was reduced to almost 50% in the UTR inserted recombinant constructs indicating that the hsa-miR-432-5p directly interacts with the UTR of the said genes. Thus, these data suggest that dysregulation of hsa-miR-432-5p could have implications on IS pathology involving the above mentioned genes. In this context, there are reports showing that TGFB3 is involved in the regulation of the immune system in that they can lead to induction of FOXP3+ CD4+ T cells [51] . As far as CELSR2 is concerned, it is known that this gene is linked to cardiovascular diseases and evidence suggests that people with cardiovascular disease have higher risk of developing stroke [52] . ITM2C is also linked to stroke. For example, it was reported that siRNA mediated knockdown of ITM2C led to increase in apoptosis and decreased survival in neuronal cells [53] .
In summary, the present work identified several dysregulated miRNAs in PBMCs from IS patients which are predicted to regulate expression of genes involved in the immune system and vascularization processes. Most importantly, we have identified four novel miRNAs that are dysregulated in IS. These miRNAs stand to be very good candidates for further analysis as epigenetic markers for IS. Further studies with larger sample sizes are required to examine the precise roles of these miRNAs and for inclusion as reliable epigenetic markers for prediction and risk stratification of IS. Also of interest is whether these miRNAs are involved in the induction of IS and could be useful in prediction of IS, or are an outcome of the IS incident. Finally, the unique miRNA signatures of IS patients could reveal more about the pathological mechanisms underlying stroke and warrant further investigation.
